New Evidence on Benzodiazepine Use and Falls: The Time Factor
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The objectives of this prospective study were to calculate incidence rates for fall-related hospitalization, to compare the effect of risk factors among benzodiazepine (BZD) users and unexposed controls, and to examine variations in risks according to length of time following a BZD prescription. Data were derived from Saskatchewan Health linked data bases, leading to information on 468 hospitalizations for injury due to falls among a study population of 321422. Incidence rates per 10000 within 28 days of the prescription fill date were 26.2, 12.1 and 9.0 for BZD sedative users, BZD tranquillizer users and for unexposed controls, respectively. Incidence rates increased with age, and were higher for women than for men. Results from multivariate logistic regression models also showed a greater risk of falling for BZD users but the odds ratio was higher for men than for women. A history of treatment for alcohol abuse was a very strong risk factor for falls among both men (odds ratio, 10.7) and women (odds ratio, 4.3). The highest risk of serious injury due to falls was within 15 days of filling the prescription, with an odds ratio of 3.6 for BZD sedatives and 2.6 for BZD tranquillizers. Risk decreased with further increase of time after the BZD fill date. For the individual BZD, flurazepam and triazolam showed the highest increase in risk with odds ratios of 3.4 and 2.7, respectively, while oxazepam, lorazepam and diazepam showed odds ratios of 2.2, 2.0 and 1.8 (all odds ratios mentioned are statistically significant at p < 0.05).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
Cited by
Medication as a Risk Factor for Falls: Critical Systematic Review
Hartikainen, S., Lonnroos, E., & Louhivuori, K. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.10.1172 · Cited by 596
Fall-risk-increasing drugs: a systematic review and meta-analysis: II. Psychotropics
Seppala, L. J., Wermelink, A. M. A. T., de Vries, M., Ploegmakers, K. J., van de Glind, E. M. M., Daams, J. G., van der Velde, N., Blain, H., Bousquet, J., Bucht, G., et al. (2018) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2017.12.098 · Cited by 517
Association between falls in elderly women and chronic diseases and drug use: cross sectional study
Lawlor, D. A., Patel, & Ebrahim, S. (2003) · BMJ · doi:10.1136/bmj.327.7417.712 · Cited by 444
Brandt, J., & Leong, C. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0207-7 · Cited by 356
“However, evidence has shown, with limited conflicting results and adherence to expected pharmacological principles, that the risk of falls and fractures increases with higher doses [51, 55, 58–60], use of interacting medications [55], and after treatment initiation, particularly during the first 1–2 weeks of drug expo…”
ResultBenzodiazepines and Risk of Hip Fractures in Older People: A Review of the Evidence
Cumming, R. G., & Le Couteur, D. G. (2003) · CNS Drugs · doi:10.2165/00023210-200317110-00004 · Cited by 332
Residual Effects of Hypnotics: Epidemiology and Clinical Implications
Vermeeren, A. (2004) · CNS Drugs · doi:10.2165/00023210-200418050-00003 · Cited by 277
Antidepressants plus benzodiazepines for major depression
Furukawa, T. A., Streiner, D., Young, L. T., & Kinoshita, Y. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001026 · Cited by 161
The Epidemiology of Long-Term Benzodiazepine Use
Neutel, C. I. (2005) · International Review of Psychiatry · doi:10.1080/09540260500071863 · Cited by 148
A systematic review of research examining benzodiazepine-related mortality
Charlson, F., Degenhardt, L., McLaren, J., Hall, W., & Lynskey, M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1694 · Cited by 107
Risk of suicide attempts after benzodiazepine and/or antidepressant use
Neutel, C. I., & Patten, S. B. (1997) · Annals of Epidemiology · doi:10.1016/s1047-2797(97)00126-9 · Cited by 88
Self-citationPrescribing psychotropic medication for elderly patients: some physicians' perspectives.
(1999) · Europe PMC (PubMed Central) · Cited by 46
Metadata
- Authors
- NEUTEL, C. I., HIRDES, J. P., MAXWELL, C. J., & PATTEN, S. B.
- Venue
- Age and Ageing
- Publisher
- Oxford University Press (OUP)
- Published
- 1996
- Volume
- 25
- Issue
- 4
- Pages
- 273-278
- ISSN
- 0002-0729 (ISSN-L)
- 1468-2834
- OpenAlex
- W2119700347
- Cited by
- 155
- References
- 1
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.